Participants’ blood samples were drawn years before their dementia diagnosis.
Sudha Seshadri, M.D., founding director of the Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases at UT Health San Antonio, is co-leader and senior author on research announced March 6 that identifies novel biomarkers of risk for future dementia.
Dementia is a rising tidal wave of devastation for families and society. Age is the biggest risk factor. Alzheimer’s disease, which is the leading cause of dementia, is the sixth-leading cause of death in the United States, and more than 5 million Americans are currently living with Alzheimer’s. That figure is expected to triple by 2050.
The discovery is described in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. The study analyzed small molecules called metabolites in blood samples drawn from 22,623 individuals, including 995 who went on to develop dementia. The p
articipants were enrolled in eight research cohorts in five countries.
Associations with lower, higher risk
Researchers found that higher blood concentrations of molecules called branched-chain amino acids were associated with lower risk of future dementia. Another molecule, creatinine, and two very low-density lipoprotein (VLDL)-specific lipoprotein lipid subclasses also were associated with lower risk of dementia.
One high-density lipoprotein (HDL) and one VLDL lipoprotein subclass were associated with increased dementia risk.
These findings will broaden the search for drug targets in dementia caused by Alzheimer’s disease, vascular disease and other subtypes, said Dr. Seshadri, professor of neurology at UT Health San Antonio. Formerly of Boston University, Dr. Seshadri is a senior investigator in the long-running Framingham Heart Study and leads the neurology working group within several international consortia.
“It is now recognized that we need to look beyond the traditionally studied amyloid and tau pathways and understand the entire spectrum of pathology involved in persons who present with symptoms of Alzheimer’s disease and other dementias,” Dr. Seshadri said. “It is exciting to find new biomarkers that can help us identify persons who are at the highest risk of dementia.”
In the future, the Glenn Biggs Institute may investigate the feasibility of developing a diagnostic exam, such as a blood test, to assess each patient’s molecular signature of dementia risk. The signature could include blood concentration of branched-chain amino acids. The altered metabolite signatures were observed years before the diagnosis of dementia when those study participants were healthy, Dr. Seshadri said. If a test were to become available, therapy could be initiated earlier.
The study was in persons of European ancestry and was carried out in collaboration with researchers in Finland, the Netherlands, the United Kingdom and Estonia. Dr. Seshadri is eager to replicate it in South Texas. “The Glenn Biggs Institute at UT Health San Antonio will expand these studies to include the diverse racial and ethnic groups who live in South Texas,” she said.
Branched-chain amino acids are nutrients that the body obtains from proteins in foods such as meat and legumes. These amino acids include leucine, isoleucine and valine. “Valine has previously been shown to be involved in determining the risk of diabetes, which is a particularly big problem in our region, especially among the region’s large Hispanic population,” Dr. Seshadri said. “Now it is shown to be associated with the risk of Alzheimer’s dementia. We want to investigate for any connections.”
Metabolites are influenced by genetic and environmental factors, and their levels can be modified through dietary and pharmacological interventions. “I hope that people reading about this study will understand that they can take ownership of their health,” Dr. Seshadri said. “The lifestyle decisions they make, such as adopting a Mediterranean or other healthful diet, can affect these metabolites in ways we do not fully understand.”
Further studies can clarify whether the branched-chain amino acids and other molecules play a causal role in the dementia disease process or are merely early markers of the disease, Dr. Seshadri said.
The Latest on: Dementia risk
- Can managing cholesterol reduce Alzheimer’s risk? on November 12, 2018 at 12:00 pm
Their analysis confirmed that six of the 90 regions had very strong effects on Alzheimer's and heightened blood lipid levels, including several within genes that had not previously been linked to deme... […]
- Five-minute neck scan could predict dementia risk on November 12, 2018 at 2:28 am
A five-minute scan of blood vessels in the neck during mid-life could become part of future dementia screening, researchers have suggested. If confirmed in larger studies, the scan - which predicts co... […]
- Five-minute neck scan could indicate dementia risk on November 12, 2018 at 1:08 am
A five-minute neck scan could predict cognitive decline 10 years before symptoms appear, according to scientists. Researchers suggest the quick scan of blood vessels may become a routine part of ... […]
- New ‘neck scan’ could detect those at risk of dementia on November 11, 2018 at 11:04 pm
SCIENTISTS have revealed a ‘neck scan’ which can be used to detect people who are at risk of dementia before any symptoms appear. A study of 3000 people over a 15 year period showed that those with th... […]
- Dementia risk: Five-minute scan 'can predict cognitive decline' on November 11, 2018 at 5:20 pm
A five-minute scan could be used to spot people at risk of dementia before symptoms appear, researchers claim. Scientists used ultrasound scanners to look at blood vessels in the necks of more than 3, ... […]
- Five-minute test identifies those at higher risk of dementia TEN years before first symptoms appear on November 11, 2018 at 3:16 pm
A FIVE-minute test can detect those at highest risk of dementia – a decade before the earliest symptoms appear. Experts found scanning blood vessels in the neck helped predict whether a middle-aged Br... […]
- Risk Factors for Developing Dementia Within 10-Years ID’d — Interventions Reduce Risk on November 9, 2018 at 7:15 pm
A new Danish study provides a method to identify people at high risk of developing dementia within a 10-year frame. Experts believe detecting high-risk individuals is critical as early targeted ... […]
- Is Anxiety a Risk Factor for Dementia Later in Life? on November 9, 2018 at 8:33 am
Recent research out of the U.K. looked into the link between anxiety and the onset of dementia later in life. The meta-analysis examined four large studies of about 30,000 subjects and concluded ... […]
- A Surprising Risk Factor for Dementia on November 7, 2018 at 4:19 am
A new Florida State University College of Medicine study involving data from 12,000 participants collected over 10 years confirms the heavy toll that loneliness can take on your health: It ... […]
- Head Injury Tied to Long-term Cognitive Decline, Dementia Risk on November 5, 2018 at 2:43 am
ATLANTA — A history of head injury is common in the United States and is associated with steeper long-term cognitive decline and a greater risk for dementia over the following 20 years than not having ... […]
via Google News and Bing News